Close X
Tuesday, November 26, 2024
ADVT 
Health

'Off switch' for pain discovered

Darpan News Desk IANS, 30 Nov, 2014 01:48 PM
    Researchers have uncovered a new way to block neuropathic pain including pain caused by chemotherapeutic agents and bone cancer.
     
    Turning on a receptor called A3 in the brain and spinal cord could quell pain, the results of the research found.
     
    The receptor can be activated by its chemical stimulator, the small molecule adenosine.
     
    "It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain," said researcher Daniela Salvemini from the Saint Louis University in the US.
     
    "Our findings suggest that this goal may be achieved by focusing future work on the A3AR (adenosine receptor) pathway as its activation provides robust pain reduction across several types of pain," Salvemini added.
     
    The most successful pharmacological approaches for the treatment of chronic pain rely on certain pathways: circuits involving opioid, adrenergic and calcium channels.
     
    For the past decade, scientists have tried to take advantage of these known pathways where the series of interactions between molecular-level components take place that consequently lead to pain.
     
    While adenosine had shown potential for pain-killing in humans, researchers had not successfully leveraged this particular pain pathway because the targeted receptor engaged many side effects.
     
    In this research on animal models, Salvemini and colleagues demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
     
    The study appeared in the journal Brain.

    MORE Health ARTICLES

    Flawed gene may curb heart attack risk by half

    Flawed gene may curb heart attack risk by half
    Rare mutations that shut down a single gene called NPC1L1 are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, says an Indian-origin cardiologist....

    Flawed gene may curb heart attack risk by half

    Vitamin B doesn't stem memory loss

    Vitamin B doesn't stem memory loss
    A day before Indian Prime Minister Narendra Modi arrives in Brisbane for the G20 summit, Australia is waiting anxiously for the Indian Prime Minister's overdue visit to commence....

    Vitamin B doesn't stem memory loss

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence
    TORONTO — Canadian researchers have developed a genetic test to identify which men are at highest risk for recurrence of prostate cancer following localized treatment with surgery or radiation therapy.

    Personalized Genetic Test Could Predict Prostate Cancer Recurrence

    Oral cancer virus spreads via oral, genital route

    Oral cancer virus spreads via oral, genital route
    Transmission of human papillomavirus (HPV) occurs via oral-oral and oral-genital routes, says new research....

    Oral cancer virus spreads via oral, genital route

    A virus that could affect brain's activities

    A virus that could affect brain's activities
    People with algae virus in their throats had more difficulty completing a mental exercise than healthy people, and more research is needed to understand why...

    A virus that could affect brain's activities

    How mucus in mouth naturally fight cavities

    How mucus in mouth naturally fight cavities
    Salivary mucins, key components of mucus, actively protect the teeth from cavity-causing bacteria, new research shows....

    How mucus in mouth naturally fight cavities